C4 Therapeutics Inc (NASDAQ: CCCC) is 8.89% higher on its value in year-to-date trading and has touched a low of $3.43 and a high of $11.88 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CCCC stock was last observed hovering at around $3.66 in the last trading session, with the day’s gains setting it 0.26%.
Currently trading at $3.92, the stock is -2.71% and -16.09% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.8 million and changing 7.10% at the moment leaves the stock -31.52% off its SMA200. CCCC registered -32.18% loss for a year compared to 6-month loss of -13.27%. The firm has a 50-day simple moving average (SMA 50) of $4.6718 and a 200-day simple moving average (SMA200) of $5.7242.
The stock witnessed a -3.45% gain in the last 1 month and extending the period to 3 months gives it a -26.59%, and is -2.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.20% over the week and 10.33% over the month.
C4 Therapeutics Inc (CCCC) has around 145 employees, a market worth around $296.37M and $33.67M in sales. Profit margin for the company is -313.35%. Distance from 52-week low is 14.29% and -67.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.69%).
The EPS is expected to grow by 42.65% this year.
C4 Therapeutics Inc (CCCC) Top Institutional Holders
159.0 institutions hold shares in C4 Therapeutics Inc (CCCC), with institutional investors hold 103.18% of the company’s shares. The shares outstanding are 70.56M, and float is at 56.92M with Short Float at 15.58%. Institutions hold 91.41% of the Float.
The top institutional shareholder in the company is LYNX1 CAPITAL MANAGEMENT LP with over 6.88 million shares valued at $31.79 million. The investor’s holdings represent 9.9993% of the CCCC Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 4.88 million shares valued at $22.54 million to account for 7.0891 of the shares outstanding. The other top investors are WASATCH ADVISORS LP which holds 4.85 million shares representing 7.0442% and valued at over $22.39 million, while BLACKROCK INC. holds 6.6146 of the shares totaling 4.55 million with a market value of $21.03 million.
C4 Therapeutics Inc (CCCC) Insider Activity
#####
Still, SEC filings show that on Oct 11 ’24, Salter Malcolm (Director) Proposed Sale 8,561 shares at an average price of $5.38 for $46061.0. The insider now directly holds shares of C4 Therapeutics Inc (CCCC).
